Can your primary care doctor prescribe GLP-1? Yes, and here is when to use them instead of telehealth

TLDR. Most US primary care doctors can write a GLP-1 prescription, but most patients go to telehealth because the path is faster, prices are clearer, and same-day starts are realistic. Telehealth wins for cash-pay, time-constrained, and PA-experienced patients. Primary care wins in four scenarios: complex comorbidities (T1D, CKD, pregnancy planning), insurance with restrictive specialist requirements, prescriber relationship needed for long-term documentation, and patients who already have a chart of weight measurements making PA easier.

The single most common question we get from readers who already have a primary care doctor: do I really need a telehealth program at all? Can my PCP just write the prescription?

The short answer: yes, in almost every state a PCP can prescribe Wegovy or Zepbound for an appropriate patient. The longer answer is that "can" and "will" are different things, and your PCP's willingness depends on factors that have nothing to do with you.

Why most people use telehealth instead

Three reasons that come up repeatedly:

• PCP wait times. The median wait for a new PCP appointment in the US in 2024 was 26 days. For an established patient adding a new condition to an existing visit, you usually wait until your next physical. Telehealth gets you on medication in 1-7 days.
• PCP discomfort with GLP-1. Many PCPs trained before GLP-1s became weight-loss-first medications. They are comfortable with metformin and lisinopril; they are less comfortable initiating a $400/month injectable. This is changing, but slowly.
• The 15-minute appointment. Initiating a GLP-1 properly requires a conversation about diet, side effects, titration and what to do at month 6. That conversation takes 30-45 minutes, not the 15 minutes your PCP has scheduled.

When the PCP path is actually better

Four scenarios where we would recommend the PCP route over telehealth:

1. You have an obesity-medicine PCP

If your PCP is board-certified in obesity medicine (ABOM certification, you can verify on the American Board of Obesity Medicine website), use them. They will write the prior auth letter correctly, monitor labs at appropriate intervals and adjust dosing based on real clinical context. No telehealth program will out-perform a competent obesity-medicine specialist.

2. You have complex comorbidities

Type 2 diabetes, cardiovascular disease, kidney disease, history of pancreatitis, history of medullary thyroid carcinoma, multiple psychiatric medications. If you have more than one of these, an in-person clinician who reads your full chart beats a telehealth visit. The GLP-1 prescription is the easy part; the harder part is coordinating it with your other medications.

3. You have already failed an SSRI weight-gain or a steroid weight-gain

Iatrogenic weight gain (caused by medications you need for another condition) is the strongest medical case for GLP-1. Your PCP already knows the context; you do not need to re-explain it to a telehealth clinician who has access only to your intake form.

4. Your insurance is restrictive

If your plan has step therapy (you must try and fail on phentermine before they will approve a GLP-1), only an established PCP can document the failure correctly. Telehealth programs can do this in principle, but the volume of step-therapy denials we see suggests they often do not.

When telehealth is actually better

Five scenarios where telehealth wins:

• You are cash-pay (no insurance) and want the cheapest path. Compounded GLP-1 through Mochi or Henry Meds is faster and cheaper than anything a PCP can do.
• You want to start within a week. Telehealth standard is 1-5 days; PCP standard is 2-6 weeks.
• Your PCP has already declined. Some PCPs simply will not prescribe GLP-1 for weight loss. If yours has said no, do not waste another visit trying to change their mind; switch tracks.
• You are on a less standard schedule (compounded titration, off-label dose, weekend titration). Telehealth handles these without judgment.
• You value privacy. Some patients do not want a GLP-1 prescription in their primary chart. Telehealth keeps it separate. This is a real, legitimate preference.

The hybrid that often works best

Many of the patients we hear from end up with: telehealth program writes the script, PCP monitors labs and watches for drug interactions. The telehealth visit costs $40-$200/month; the PCP visit happens at your usual annual physical with no extra cost.

This hybrid works if your PCP knows you are on a GLP-1 and the rest of your care continues normally. Do not hide the prescription from your PCP; that creates real safety risks.

If you want a primary-care-style telehealth

Knownwell sits closest to the PCP model on telehealth: real obesity-medicine clinicians, longer appointments, integrated labs, primary-care continuity. Form Health is the second closest. Both are more expensive than the cash-pay compounded options because the clinical model costs more, but they replicate more of what a PCP would offer.

If you want a true one-off prescription with no ongoing relationship, Sesame Care offers single-visit prescribing for patients who already know the medication and just need a script.

See our cash-pay rankings for the most affordable telehealth path, or the insurance-friendly programs if a PCP is not on the table.

Frequently asked questions

Can my primary care doctor prescribe Wegovy or Zepbound?

Yes, in almost all US states. GLP-1 medications are not specialist-restricted. Family physicians, internists, and obesity-medicine board-certified PCPs all prescribe them routinely. The barrier is not authority; it is workflow. PCPs who have not built prior authorization infrastructure may take longer to file a PA than a dedicated obesity-medicine telehealth program.

When does telehealth beat primary care for GLP-1?

Three common scenarios. Cash-pay patients who want a same-week start at a known price. Patients with a clear path to compounded semaglutide who do not want to argue PA. Patients in markets with long PCP wait times (urban or rural where 4 to 8 week appointment delays are common).

When does primary care beat telehealth for GLP-1?

Four scenarios. Complex comorbidities (type 1 diabetes, chronic kidney disease, pregnancy planning) where coordination with other specialists matters. Insurance plans that restrict GLP-1 prescriptions to in-network specialists. Documentation continuity (your PCP already has 6 months of weight measurements, making PA easier). Long-term care relationship where the same prescriber follows you indefinitely.

Is one path more likely to win prior authorization?

Slightly. The PA win rate is driven by documentation quality, not prescriber type. A PCP who routinely runs PAs and writes detailed letters wins at the same rate as a dedicated telehealth program. A PCP who has not done this before often loses on documentation gaps. Telehealth programs that specialize in obesity medicine have invested in PA infrastructure.

Is one path cheaper?

Depends on insurance. With PA-approved commercial insurance, both paths land at the same $25 to $150 copay. Cash-pay telehealth (compounded at $99 to $199 or brand at $149+ via NovoCare/LillyDirect) is usually cheaper than PCP visits plus brand cash medication for uninsured patients. Insured patients with low copays may pay less through PCP because they avoid the membership fee.